The release of HMGB1 by necrotic cells can enhance inflammatory responses, tumor formation, and metastasis through the release of proinflammatory cytokines by activating proinflammatory signaling pathways, including NF-κB and inflammasome pathways [14, 77–80, 201]. The gene discussed is HMGB1; the disease is neoplasm.